The analysis by IPA of the genes potentially targeted by the identified miRs on the basis of sequence complementarity identified a gene network involving TNFRSF8/CD30 and other genes potentially contributing to defective tumor immunity. The gene discussed is TNFRSF8; the disease is neoplasm.